| Literature DB >> 32502987 |
Richard T Hoppe1, Ranjana H Advani1, Weiyun Z Ai2, Richard F Ambinder3, Philippe Armand4, Celeste M Bello5, Cecil M Benitez1, Philip J Bierman6, Kirsten M Boughan7, Bouthaina Dabaja8, Leo I Gordon9, Francisco J Hernandez-Ilizaliturri10, Alex F Herrera11, Ephraim P Hochberg12, Jiayi Huang13, Patrick B Johnston14, Mark S Kaminski15, Vaishalee P Kenkre16, Nadia Khan17, Ryan C Lynch18, Kami Maddocks19, Jonathan McConathy20, Matthew McKinney21, Monika Metzger22, David Morgan23, Carolyn Mulroney24, Rachel Rabinovitch25, Karen C Rosenspire26, Stuart Seropian27, Randa Tao28, Jane N Winter9, Joachim Yahalom29, Jennifer L Burns30, Ndiya Ogba30.
Abstract
The NCCN Clinical Practice Guidelines in Oncology for Hodgkin Lymphoma (HL) provide recommendations for the management of adult patients with HL. The NCCN panel meets at least annually to review comments from reviewers within their institutions, examine relevant data, and reevaluate and update their recommendations. Current management of classic HL involves initial treatment with chemotherapy alone or combined modality therapy followed by restaging with PET/CT to assess treatment response. Overall, the introduction of less toxic and more effective regimens has significantly advanced HL cure rates. This portion of the NCCN Guidelines focuses on the management of classic HL.Entities:
Mesh：
Year: 2020 PMID： 32502987 DOI： 10.6004/jnccn.2020.0026
Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908